Articles by Park Han-na
Park Han-na
hnpark@heraldcorp.com-
NPS to pour W1tr more into local stocks this year
[THE INVESTOR] South Korea’s state-run National Pension Services, which oversees over 540 trillion won (US$473 billion), will pour 1 trillion won into local equities by the end of this year, the public pension fund said on Oct. 26. In early November, the NPS will pick 12 asset management companies to run the fund who will be divided into three groups based on their investment specializations -- value stock, small and mid-cap stock and those who use quantitative stock selection techniques. Indust
Oct. 27, 2016
-
Hanmi Pharma’s Q3 operating profit plunges 62%
[THE INVESTOR] South Korean drug maker Hanmi Pharmaceutical said on Oct. 27 that its operating profit plunged 61.6 percent in the third quarter compared with the previous year when the firm’s revenue surged after winning a blockbuster licensing deal from German pharma giant Boehringer Ingelheim. Operating profit came to 13.77 billion won (US$12.10 million) on consolidated basis, while sales decreased 18.1 percent to 219.72 billion won in the quarter ended on Sept. 30. It swung to a net profit of
Oct. 27, 2016
-
Naver’s Q3 revenue breaks W1tr mark
[THE INVESTOR] South Korean internet giant Naver on Thursday reported that its third-quarter revenue surged 20.5 percent on-year to reach 1.01 trillion won ($890 million), led by growing sales from its overseas and mobile businesses. It is the first time ever that Naver’s quarterly earnings have surpassed 1 trillion won, the company said in a regulatory filing. In the July-September period, Naver’s operating profit surged 27.6 percent from a year earlier to 282.3 billion won. Its consolidated n
Oct. 27, 2016
-
Naver maintains 30% dividend payout ratio
[THE INVESTOR] Naver, South Korea’s top internet portal operator, will continue to maintain a dividend payout ratio of 30 percent, the company said on Oct. 27. “Since 2009, we have been giving 30 percent of net income to shareholders and we will continue to do so,” Naver said during a conference call to discuss its third-quarter financial and operating results. It also added that the company has no plan to retire its treasury stocks. The company's net profit surged 69.5 percent from a year earli
Oct. 27, 2016
-
Korean institutional investors fund Air France
[THE INVESTOR] South Korea’s two institutional investors have made an investment in aircraft financing for French flag carrier Air France, according to sources on Oct. 26. Public Officials Benefit Association and Korea Federation of SMEs invested US$34 million through mezzanine financing in a Boeing B777-300ER that will be leased to Air France on a 7-year term with an expected annual return of 5 to 6 percent a year. Air France seeks to secure a total of US$115.7 million for the jet in which some
Oct. 26, 2016
-
Sungjee Construction merges with IB Pharm
[THE INVESTOR] Sungjee Construction, South Korea’s midsized builder, has decided to merge with its subsidiary IB Pharm in a bid to diversify its business portfolio to the pharmaceutical sector, the company said on Oct. 26. IB Pharm is a wholesale distributor of pharma and medical products, which is entirely owned by Sungjee Construction.The builder said the merger would help the company to increase business efficiency as it could reduce consumption of resources and manpower than keeping IB Pharm
Oct. 26, 2016
-
CLIO to tap deeper into Chinese cosmetics market
[THE INVESTOR] South Korea’s cosmetics maker CLIO, which seeks to get listed on the Seoul bourse next month, will target China’s growing color makeup market, the firm said on Oct. 24. “Cosmetics are now regarded as a tool to express ‘myself’ departing from its traditional role of protecting skin. The trend is remarkably strong among Chinese youngsters,” CLIO’s chief executive Han Hyun-ok said during a press conference in Seoul. On the back of K-beauty boom, CLIO has been expanding its foothold i
Oct. 24, 2016
-
Great Rich Technologies to debut on KOSDAQ
[THE INVESTOR] China’s Great Rich Technologies got approval on Oct. 24 from the Korea Exchange to list on South Korea’s secondary KOSDAQ market. The stock trading will kick off on Oct. 25 with the initial offering price of 5,000 won (US$4.41). Korea Exchange headquartersEstablished in 2012, Hong Kong-based Great Rich Technologies is a holding company of its subsidiary that manufactures optical and protective film. GRT posted a net profit of 164.5 billion won (US$144.9 million) and a sale of 35 b
Oct. 24, 2016
-
Korea’s air carriers to log solid Q3 earnings: analyst
[THE INVESTOR] South Korea’s major air carriers Korean Air Lines, Asiana Airlines and Jeju Air are expected to beat earnings estimates in the third quarter thanks to rising air traffic and low oil prices, a local brokerage said on Oct. 24. According to Samsung Securities, the combined revenue and operating profit of the three air carriers are likely to increase 7.4 percent and 59 percent to log 5 trillion won (US$4.47 billion) and 597.1 billion won, respectively, in the July-September period. An
Oct. 24, 2016
-
France’s DCNS eyes French unit of STX Offshore
[THE INVESTOR] France’s state-run shipyard DCNS is mulling a bid to acquire STX France, the French unit of South Korea’s troubled shipyard STX Offshore & Shipbuilding which is under court receivership, according to industry sources on Oct. 21. Since the Korean bankruptcy court announced on Oct. 19 that it would sell its entire stake in STX Shipbuilding and a 66.7 percent stake in STX France, speculation has been rising about potential bidders, including DCNS. The price of the package deal is est
Oct. 21, 2016
-
Daehwa cancels export contract with Taiwan’s LOTUS
[THE INVESTOR] Daewha Pharmaceutical said on Oct. 20 that it has terminated its contract with Taiwan’s LOTUS Pharmaceutical to export their co-developed topical anesthetic topical lidocaine patch 5%. The South Korean drug maker blamed LOTUS for the fallout of the 42.3 billion won deal, saying the Taiwanese partner failed to receive regulatory approvals in China, Europe and the US for the local anesthetic patch, which was one of the preconditions of the contract. Daehwa said it will receive US$3
Oct. 20, 2016
-
Englewood Lab shares surge over 20%
[THE INVESTOR] Englewood Lab shares soared more than 65 percent above their initial public offering price on Oct. 20 after its stock market debut on South Korea’s secondary KOSDAQ last week. Shares in the US cosmetics ingredient manufacture climbed 21.69 percent to close at 9,930 won (US$8.81), against their 6,000 won initial sale price. This is in stark contrast to its first day on the stock market when the share price tumbled 12.68 percent. Established in 2004, the ODM company has provided ski
Oct. 20, 2016
-
DCNS interested in buying STX France: report
[THE INVESTOR] French naval contractor DCNS is considering making a bid for STX France, a unit of South Korea’s bankrupted shipbuilding group, a local media outlet reported on Oct. 20. According to the Korea Economic Daily, the French firm discussed a possible acquisition of STX France’ stake, owned by STX Offshore & Shipbuilding which filed for receivership in May. DCNS could not be reached for comment. On Oct. 19, the South Korean bankruptcy court that oversees the ship year’s receivership off
Oct. 20, 2016
-
Shinhan Bank invests $30m in IFC’s emerging market fund
[THE INVESTOR] Shinhan Bank, South Korea‘s fourth-largest bank by assets, has invested some US$30 million into a fund run by the International Finance Corporation, targeting financial institutions in emerging markets, the firm said on Oct. 19. The bank inked a memorandum of understanding with the IFC, the private sector arm of the World Bank Group, to work together to seek investment opportunities in promising projects in emerging countries. “We expect that the partnership will help us to create
Oct. 19, 2016
-
Celltrion’s Remsima exports surpass W1tr
[THE INVESTOR] Total accumulated exports of Celltrion’s Remsima, a biosimilar version of Johnson & Johnson’s Remicade, have exceeded 1 trillion won (US$890 million), the South Korean drug maker’s overseas marketing affiliate Celltrion Healthcare said on Oct. 19. It took four years for Celltrion to reach the figure since the pharmaceutical firm shipped the first batch of its rheumatoid arthritis treatment drug Remsima in 2012. “The exports of Remsima are expected to rise at a faster clip if the d
Oct. 19, 2016
Most Popular
-
1
Industry experts predicts tough choices as NewJeans' ultimatum nears
-
2
Jung's paternity reveal exposes where Korea stands on extramarital babies
-
3
Samsung entangled in legal risks amid calls for drastic reform
-
4
Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul
-
5
[Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'
-
6
Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
-
7
[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance
-
8
[Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle
-
9
Prosecutors seek 5-year prison term for Samsung chief in merger retrial
-
10
UN talks on plastic pollution treaty begin with grim outlook